Literature DB >> 26867852

Refractory Case of Paroxysmal Autonomic Instability With Dystonia Syndrome Secondary to Hypoxia.

John Kern1, Daniel Bodek2, Osama Tariq Niazi2, James Maher2.   

Abstract

Paroxysmal autonomic instability with dystonia (PAID) is a syndrome commonly related to traumatic brain injury (TBI) and rarely to anoxia associated with symptoms of dystonia, tachycardia, tachypnea, and diaphoresis. This is a case of a 20-year-old man who was stabbed in the heart. He underwent surgical repair of a ventricular septal defect and mitral valve replacement. Postoperatively, he developed dystonia with tachycardia and tachypnea consistent with PAID syndrome, secondary to prolonged hypoxia. Traditionally, this poorly understood syndrome is treated with morphine, clonazepam, and nonselective β-blockers. Second-line medications commonly used are baclofen, dantrolene, and gabapentin, which are aimed at the dystonia itself. In this case, both first- and second-line agents were ineffective. A 72-hour dexmedetomidine infusion resulted in complete resolution of symptoms. This is the first case of anoxia-induced PAID syndrome to be effectively treated with dexmedetomidine, which was previously used in a case induced by TBI.
Copyright © 2016 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  autonomic function; cardiac arrest; neurology; trauma

Mesh:

Substances:

Year:  2016        PMID: 26867852     DOI: 10.1016/j.chest.2015.08.003

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  2 in total

1.  The Pseudodystonia of Paroxysmal Sympathetic Hyperactivity: A Reversible Post-Anoxic Complication.

Authors:  Harsh V Gupta; Vibhash D Sharma; Alberto J Espay
Journal:  Mov Disord Clin Pract       Date:  2020-10-19

2.  The preventive effect of dexmedetomidine on paroxysmal sympathetic hyperactivity in severe traumatic brain injury patients who have undergone surgery: a retrospective study.

Authors:  Qilin Tang; Xiang Wu; Weiji Weng; Hongpeng Li; Junfeng Feng; Qing Mao; Guoyi Gao; Jiyao Jiang
Journal:  PeerJ       Date:  2017-02-15       Impact factor: 2.984

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.